@thedailystockmarket: Moderna Just Put Biotech Back On Wall Street’s Radar After Moderna stock went soaring 177% last week it put biotech back in the spotlight, showing how a single clinical breakthrough can instantly reshape what investors believe a company could be worth. Disclosure: This content was disseminated on behalf of Aprea Therapeutics. (NASDAQ: APRE). The creator was compensated by a third-party agency to produce this content. This content is for informational and entertainment purposes only and should not be construed as financial or investment advice. Investing in public companies involves risk, and past performance does not guarantee future results. This is not financial advice. Viewers should conduct their own research and consult a licensed financial professional before making any investment decisions.

7085

110

2026-08-26 04:18:38

To see more videos from user @thedailystockmarket, please go to the Tikwm homepage.